{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:24:33Z","timestamp":1769279073201,"version":"3.49.0"},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":535,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1111\/apm.12235","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T08:30:51Z","timestamp":1394872251000},"page":"380-391","source":"Crossref","is-referenced-by-count":8,"title":["Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice"],"prefix":"10.1111","volume":"122","author":[{"given":"Shujing","family":"Shi","sequence":"first","affiliation":[{"name":"Medical Oncology Department of Jinling Hospital; Medical school of Nanjing University; Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilei","family":"Tao","sequence":"additional","affiliation":[{"name":"Medical Oncology Department of Jinling Hospital; Medical school of Nanjing University; Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haizhu","family":"Song","sequence":"additional","affiliation":[{"name":"Medical Oncology Department of Jinling Hospital; Medical school of Nanjing University; Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longbang","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical Oncology Department of Jinling Hospital; Medical school of Nanjing University; Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guichun","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical Oncology Department of Jinling Hospital; Medical school of Nanjing University; Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,3,15]]},"reference":[{"key":"10.1111\/apm.12235-BIB0001|apm12235-cit-0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics","volume":"62","author":"Siegel","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/apm.12235-BIB0002|apm12235-cit-0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","article-title":"Immune therapy for cancer","volume":"27","author":"Dougan","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/apm.12235-BIB0003|apm12235-cit-0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.49.2.74","article-title":"T cell-based immunotherapy for cancer: a virtual reality?","volume":"49","author":"Lum","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/apm.12235-BIB0004|apm12235-cit-0004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/14653249.2011.613931","article-title":"The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells","volume":"14","author":"Rettinger","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1111\/apm.12235-BIB0005|apm12235-cit-0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/cbr.2010.0927","article-title":"Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors","volume":"26","author":"Yu","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1111\/apm.12235-BIB0006|apm12235-cit-0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/cbr.2011.1116","article-title":"Preconditioning chemotherapy with cisplatin enhances the antitumor activity of cytokine-induced killer cells in a murine melanoma model","volume":"27","author":"Chen","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1111\/apm.12235-BIB0007|apm12235-cit-0007","first-page":"1","article-title":"Clinical roundtable monograph: Recent advances in taxanes for the first-line treatment of advanced non-small cell lung cancer","volume":"10","author":"Socinski","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1111\/apm.12235-BIB0008|apm12235-cit-0008","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/07357900902744510","article-title":"Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice","volume":"28","author":"Jiang","year":"2010","journal-title":"Cancer Invest"},{"key":"10.1111\/apm.12235-BIB0009|apm12235-cit-0009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/tbj.12124","article-title":"Paclitaxel, Carboplatin, and Trastuzumab in a Neo-adjuvant Regimen for HER2-positive Breast Cancer","volume":"19","author":"Sonke","year":"2013","journal-title":"Breast J"},{"key":"10.1111\/apm.12235-BIB0010|apm12235-cit-0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-9966-32-25","article-title":"Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel\/platinum first-line chemotherapy","volume":"32","author":"Smoter","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1111\/apm.12235-BIB0011|apm12235-cit-0011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3802\/jgo.2013.24.2.154","article-title":"A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer","volume":"24","author":"Isonishi","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1111\/apm.12235-BIB0012|apm12235-cit-0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/IJWH.S7012","article-title":"Clinical trials and progress with paclitaxel in ovarian cancer","volume":"2","author":"Kumar","year":"2010","journal-title":"Int J Women's Health"},{"key":"10.1111\/apm.12235-BIB0013|apm12235-cit-0013","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oraloncology.2012.09.003","article-title":"Navarro VOral Oncol. Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent\/metastatic head and neck cancer patients","volume":"49","author":"Jim\u00e9nez","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1111\/apm.12235-BIB0014|apm12235-cit-0014","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.3.6.755","article-title":"Paclitaxel in cancer therapy","volume":"3","author":"Mekhail","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/apm.12235-BIB0015|apm12235-cit-0015","first-page":"646","article-title":"Taxol: the first of the taxanes, an important new class of antitumor agents","volume":"19","author":"Rowinsky","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1111\/apm.12235-BIB0016|apm12235-cit-0016","first-page":"55","article-title":"Taxol: mechanisms of action and resistance","volume":"15","author":"Horwitz","year":"1993","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1111\/apm.12235-BIB0017|apm12235-cit-0017","first-page":"221","article-title":"Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts","volume":"8","author":"Klement","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/apm.12235-BIB0018|apm12235-cit-0018","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00262-008-0524-3","article-title":"Anti-angiogenesis: making the tumor vulnerable to the immune system","volume":"57","author":"Griffioen","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/apm.12235-BIB0019|apm12235-cit-0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fimmu.2012.00021","article-title":"Hypoxia promotes tumor growth in linking angiogenesis to immune escape","volume":"3","author":"Chouaib","year":"2012","journal-title":"Front Immunol"},{"key":"10.1111\/apm.12235-BIB0020|apm12235-cit-0020","doi-asserted-by":"crossref","first-page":"e65757","DOI":"10.1371\/journal.pone.0065757","article-title":"Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models","volume":"8","author":"Shujing","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/apm.12235-BIB0021|apm12235-cit-0021","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2013.02.020","article-title":"Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer","volume":"335","author":"Biswas","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1111\/apm.12235-BIB0022|apm12235-cit-0022","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11095-013-0984-9","article-title":"Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel","volume":"30","author":"Patel","year":"2013","journal-title":"Pharm Res"},{"key":"10.1111\/apm.12235-BIB0023|apm12235-cit-0023","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF02983217","article-title":"Generation of CD3\u00a0+\u00a0 CD56\u00a0+\u00a0 cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells","volume":"77","author":"Hongeng","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1111\/apm.12235-BIB0024|apm12235-cit-0024","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1046\/j.1365-2168.2002.02183.x","article-title":"Borel Rinkes IH. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model","volume":"89","author":"Velde","year":"2002","journal-title":"Br J Surg"},{"key":"10.1111\/apm.12235-BIB0025|apm12235-cit-0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1111\/apm.12235-BIB0026|apm12235-cit-0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","article-title":"HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF","volume":"19","author":"Rolny","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1111\/apm.12235-BIB0027|apm12235-cit-0027","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1111\/apm.12235-BIB0028|apm12235-cit-0028","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/apm.12235-BIB0029|apm12235-cit-0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/apm.12235-BIB0030|apm12235-cit-0030","first-page":"1004","article-title":"Paclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials","volume":"1","author":"Jiang","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"10.1111\/apm.12235-BIB0031|apm12235-cit-0031","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/1535-7163.MCT-09-0960","article-title":"Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer","volume":"9","author":"Hashimoto","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/apm.12235-BIB0032|apm12235-cit-0032","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4161\/onci.21057","article-title":"Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer","volume":"1","author":"Foy","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1111\/apm.12235-BIB0033|apm12235-cit-0033","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.4161\/cbt.213","article-title":"Humantumorxenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved","volume":"2","author":"Kerbel","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/apm.12235-BIB0034|apm12235-cit-0034","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kerbel","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/apm.12235-BIB0035|apm12235-cit-0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00280-005-0163-8","article-title":"The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin","volume":"58","author":"Damber","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/apm.12235-BIB0036|apm12235-cit-0036","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/02656731003601745","article-title":"Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?","volume":"26","author":"Lee","year":"2010","journal-title":"Int J Hyperthermia"},{"key":"10.1111\/apm.12235-BIB0037|apm12235-cit-0037","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clon.2007.03.001","article-title":"The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments","volume":"19","author":"Hoogsteen","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1111\/apm.12235-BIB0038|apm12235-cit-0038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck-a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1111\/apm.12235-BIB0039|apm12235-cit-0039","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/icb.2009.77","article-title":"HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia","volume":"88","author":"Yang","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1111\/apm.12235-BIB0040|apm12235-cit-0040","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"10.1111\/apm.12235-BIB0041|apm12235-cit-0041","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G","article-title":"Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas","volume":"192","author":"Lewis","year":"2000","journal-title":"J Pathol"},{"key":"10.1111\/apm.12235-BIB0042|apm12235-cit-0042","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1111\/apm.12235-BIB0043|apm12235-cit-0043","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.mt.6300391","article-title":"Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment","volume":"16","author":"Kim","year":"2008","journal-title":"Mol Ther"},{"key":"10.1111\/apm.12235-BIB0044|apm12235-cit-0044","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/02841860500417486","article-title":"On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A","volume":"45","author":"Albertsson","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1111\/apm.12235-BIB0045|apm12235-cit-0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/CAD.0b013e3283299f36","article-title":"Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts","volume":"20","author":"Zhang","year":"2009","journal-title":"Anticancer Drugs"},{"issue":"Suppl 2","key":"10.1111\/apm.12235-BIB0046|apm12235-cit-0046","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.placenta.2010.12.011","article-title":"Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes","volume":"32","author":"Sobrevia","year":"2011","journal-title":"Placenta"},{"key":"10.1111\/apm.12235-BIB0047|apm12235-cit-0047","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood-2004-12-4942","article-title":"ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow","volume":"106","author":"Yang","year":"2005","journal-title":"Blood"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapm.12235","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:20:59Z","timestamp":1625433659000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apm.12235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,15]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1111\/apm.12235","relation":{},"ISSN":["0903-4641"],"issn-type":[{"value":"0903-4641","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,15]]}}}